Author Correction: HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration
The original version of this Article contained an error in the Methods section ‘Viruses and drugs’. The timing for drug treatment of CHME3 4 × 4 or 293T cells with γ-secretase inhibitor or BACE1 inhibitor was incorrectly given as ‘1 day prior to infection or transfection’ and should have stated ‘4 o...
Guardado en:
Autores principales: | Qingqing Chai, Vladimir Jovasevic, Viacheslav Malikov, Yosef Sabo, Scott Morham, Derek Walsh, Mojgan H. Naghavi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c026654b4044287a63e0ddea5d16de2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration
por: Qingqing Chai, et al.
Publicado: (2017) -
Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
por: Marlies Gijs, et al.
Publicado: (2021) -
Generation of amyloid-β is reduced by the interaction of calreticulin with amyloid precursor protein, presenilin and nicastrin.
por: Nina Stemmer, et al.
Publicado: (2013) -
Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
por: Li Zhao, et al.
Publicado: (2021) -
Cytotoxic aggregation and amyloid formation by the myostatin precursor protein.
por: Carlene S Starck, et al.
Publicado: (2010)